{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:05:36Z","timestamp":1773338736238,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-03927-5","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:25:28Z","timestamp":1772555128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stage-Dependent mediation of white matter hyperintensities between plasma biomarkers and cognitive function in Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Hui Juan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"3927_CR1","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1093\/eurheartj\/ehz100","volume":"40","author":"SR Cox","year":"2019","unstructured":"Cox SR, Lyall DM, Ritchie SJ, Bastin ME, Harris MA, Buchanan CR, et al. Associations between vascular risk factors and brain MRI indices in UK Biobank. Eur Heart J. 2019;40:2290\u2013300.","journal-title":"Eur Heart J"},{"key":"3927_CR2","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1212\/WNL.0000000000000505","volume":"82","author":"RP Kloppenborg","year":"2014","unstructured":"Kloppenborg RP, Nederkoorn PJ, Geerlings MI, van den Berg E. Presence and progression of white matter hyperintensities and cognition: a meta-analysis. Neurology. 2014;82:2127\u201338.","journal-title":"Neurology"},{"key":"3927_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-12-126","volume":"12","author":"N Bolandzadeh","year":"2012","unstructured":"Bolandzadeh N, Davis JC, Tam R, Handy TC, Liu-Ambrose T. The association between cognitive function and white matter lesion location in older adults: a systematic review. BMC Neurol. 2012;12:126.","journal-title":"BMC Neurol"},{"key":"3927_CR4","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3233\/JAD-191005","volume":"73","author":"YL Wang","year":"2020","unstructured":"Wang YL, Chen W, Cai WJ, Hu H, Xu W, Wang ZT, et al. Associations of white matter hyperintensities with cognitive decline: A longitudinal study. J Alzheimers Dis. 2020;73:759\u201368.","journal-title":"J Alzheimers Dis"},{"key":"3927_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3233\/JAD-180982","volume":"68","author":"A Damulina","year":"2019","unstructured":"Damulina A, Pirpamer L, Seiler S, Benke T, Dal-Bianco P, Ransmayr G, et al. White matter hyperintensities in Alzheimer\u2019s disease: A lesion probability mapping study. J Alzheimers Dis. 2019;68:789\u201396.","journal-title":"J Alzheimers Dis"},{"key":"3927_CR6","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1212\/01.wnl.0000249119.95747.1f","volume":"67","author":"M Yoshita","year":"2006","unstructured":"Yoshita M, Fletcher E, Harvey D, Ortega M, Martinez O, Mungas DM, et al. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology. 2006;67:2192\u20138.","journal-title":"Neurology"},{"key":"3927_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac150","volume":"4","author":"L Lorenzini","year":"2022","unstructured":"Lorenzini L, Ansems LT, Lopes Alves I, Ingala S, V\u00e1llez Garc\u00eda D, Tomassen J, et al. Regional associations of white matter hyperintensities and early cortical amyloid pathology. Brain Commun. 2022;4:fcac150.","journal-title":"Brain Commun"},{"key":"3927_CR8","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1177\/0271678X20957604","volume":"41","author":"L P\u00e5lhaugen","year":"2021","unstructured":"P\u00e5lhaugen L, Sudre CH, Tecelao S, Nakling A, Almdahl IS, Kalheim LF, et al. Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns. J Cereb Blood Flow Metab. 2021;41:1162\u201374.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3927_CR9","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1017\/S1355617712000677","volume":"18","author":"JJ Soriano-Raya","year":"2012","unstructured":"Soriano-Raya JJ, Miralbell J, L\u00f3pez-Cancio E, Bargall\u00f3 N, Arenillas JF, Barrios M, et al. Deep versus periventricular white matter lesions and cognitive function in a community sample of middle-aged participants. J Int Neuropsychol Soc. 2012;18:874\u201385.","journal-title":"J Int Neuropsychol Soc"},{"key":"3927_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1212\/01.wnl.0000316799.86917.37","volume":"71","author":"LC Silbert","year":"2008","unstructured":"Silbert LC, Nelson C, Howieson DB, Moore MM, Kaye JA. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology. 2008;71:108\u201313.","journal-title":"Neurology"},{"key":"3927_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. AJR Am J Roentgenol. 1987;149:351\u20136.","journal-title":"AJR Am J Roentgenol"},{"key":"3927_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.biopsych.2008.03.024","volume":"64","author":"KW Kim","year":"2008","unstructured":"Kim KW, MacFall JR, Payne ME. Classification of white matter lesions on magnetic resonance imaging in elderly persons. Biol Psychiatry. 2008;64:273\u201380.","journal-title":"Biol Psychiatry"},{"key":"3927_CR13","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.2147\/NDT.S207069","volume":"15","author":"RR Li","year":"2019","unstructured":"Li RR, He YS, Liu M, Nie ZY, Huang LH, Lu Z, et al. Analysis of correlation between cerebral perfusion and KIM score of white matter lesions in patients with Alzheimer\u2019s disease. Neuropsychiatr Dis Treat. 2019;15:2705\u201314.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3927_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1212\/WNL.0000000000002352","volume":"86","author":"M Marnane","year":"2016","unstructured":"Marnane M, Al-Jawadi OO, Mortazavi S, Pogorzelec KJ, Wang BW, Feldman HH, et al. Periventricular hyperintensities are associated with elevated cerebral amyloid. Neurology. 2016;86:535\u201343.","journal-title":"Neurology"},{"key":"3927_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neurobiolaging.2018.03.028","volume":"68","author":"KE Osborn","year":"2018","unstructured":"Osborn KE, Liu D, Samuels LR, Moore EE, Cambronero FE, Acosta LMY, et al. Cerebrospinal fluid \u03b2-amyloid(42) and neurofilament light relate to white matter hyperintensities. Neurobiol Aging. 2018;68:18\u201325.","journal-title":"Neurobiol Aging"},{"key":"3927_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, et al. Blood-based biomarkers for Alzheimer\u2019s disease: Towards clinical implementation. Lancet Neurol. 2022;21:66\u201377.","journal-title":"Lancet Neurol"},{"key":"3927_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr., Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"3927_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3233\/JAD-140276","volume":"42","author":"MW Bondi","year":"2014","unstructured":"Bondi MW, Edmonds EC, Jak AJ, Clark LR, Delano-Wood L, McDonald CR, et al. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. J Alzheimers Dis. 2014;42:275\u201389.","journal-title":"J Alzheimers Dis"},{"key":"3927_CR19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:270\u20139.","journal-title":"Alzheimers Dement"},{"key":"3927_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1474-4422(19)30368-0","volume":"19","author":"F Jessen","year":"2020","unstructured":"Jessen F, Amariglio RE, Buckley RF, van der Flier WM, Han Y, Molinuevo JL, et al. The characterisation of subjective cognitive decline. Lancet Neurol. 2020;19:271\u20138.","journal-title":"Lancet Neurol"},{"key":"3927_CR21","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.jalz.2017.01.015","volume":"13","author":"DR Roalf","year":"2017","unstructured":"Roalf DR, Moore TM, Mechanic-Hamilton D, Wolk DA, Arnold SE, Weintraub DA, et al. Bridging cognitive screening tests in neurologic disorders: A crosswalk between the short Montreal Cognitive Assessment and Mini-Mental State Examination. Alzheimers Dement. 2017;13:947\u201352.","journal-title":"Alzheimers Dement"},{"key":"3927_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.915009","volume":"14","author":"W Zhu","year":"2022","unstructured":"Zhu W, Huang H, Zhou Y, Shi F, Shen H, Chen R, et al. Automatic segmentation of white matter hyperintensities in routine clinical brain MRI by 2D VB-Net: A large-scale study. Front Aging Neurosci. 2022;14:915009.","journal-title":"Front Aging Neurosci"},{"key":"3927_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neurobiolaging.2014.07.019","volume":"36","author":"AM Brickman","year":"2015","unstructured":"Brickman AM, Zahodne LB, Guzman VA, Narkhede A, Meier IB, Griffith EY, et al. Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer\u2019s disease incidence. Neurobiol Aging. 2015;36:27\u201332.","journal-title":"Neurobiol Aging"},{"key":"3927_CR24","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1002\/alz.13057","volume":"19","author":"A Garnier-Crussard","year":"2023","unstructured":"Garnier-Crussard A, Cotton F, Krolak-Salmon P, Ch\u00e9telat G. White matter hyperintensities in Alzheimer\u2019s disease: Beyond vascular contribution. Alzheimers Dement. 2023;19:3738\u201348.","journal-title":"Alzheimers Dement"},{"key":"3927_CR25","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/alz.12410","volume":"18","author":"A Garnier-Crussard","year":"2022","unstructured":"Garnier-Crussard A, Bougacha S, Wirth M, Dautricourt S, Sherif S, Landeau B, et al. White matter hyperintensity topography in Alzheimer\u2019s disease and links to cognition. Alzheimers Dement. 2022;18:422\u201333.","journal-title":"Alzheimers Dement"},{"key":"3927_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13195-019-0521-0","volume":"11","author":"C Puzo","year":"2019","unstructured":"Puzo C, Labriola C, Sugarman MA, Tripodis Y, Martin B, Palmisano JN, et al. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer\u2019s Coordinating Center Uniform Data Set. Alzheimers Res Ther. 2019;11:64.","journal-title":"Alzheimers Res Ther"},{"key":"3927_CR27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1212\/01.WNL.0000130530.55104.B5","volume":"63","author":"M Tullberg","year":"2004","unstructured":"Tullberg M, Fletcher E, DeCarli C, Mungas D, Reed BR, Harvey DJ, et al. White matter lesions impair frontal lobe function regardless of their location. Neurology. 2004;63:246\u201353.","journal-title":"Neurology"},{"key":"3927_CR28","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1007\/s11682-019-00151-2","volume":"14","author":"A Brugulat-Serrat","year":"2020","unstructured":"Brugulat-Serrat A, Salvad\u00f3 G, Sudre CH, Grau-Rivera O, Su\u00e1rez-Calvet M, Falcon C, et al. Patterns of white matter hyperintensities associated with cognition in middle-aged cognitively healthy individuals. Brain Imaging Behav. 2020;14:2012\u201323.","journal-title":"Brain Imaging Behav"},{"key":"3927_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neurobiolaging.2020.03.008","volume":"91","author":"P Walsh","year":"2020","unstructured":"Walsh P, Sudre CH, Fiford CM, Ryan NS, Lashley T, Frost C, et al. CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer\u2019s disease. Neurobiol Aging. 2020;91:5\u201314.","journal-title":"Neurobiol Aging"},{"key":"3927_CR30","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1093\/brain\/awz162","volume":"142","author":"J Graff-Radford","year":"2019","unstructured":"Graff-Radford J, Arenaza-Urquijo EM, Knopman DS, Schwarz CG, Brown RD, Rabinstein AA, et al. White matter hyperintensities: relationship to amyloid and tau burden. Brain. 2019;142:2483\u201391.","journal-title":"Brain"},{"key":"3927_CR31","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/STROKEAHA.117.016990","volume":"49","author":"SM Greenberg","year":"2018","unstructured":"Greenberg SM, Charidimou A. Diagnosis of cerebral amyloid angiopathy: Evolution of the boston criteria. Stroke. 2018;49:491\u20137.","journal-title":"Stroke"},{"key":"3927_CR32","doi-asserted-by":"publisher","first-page":"e0195838","DOI":"10.1371\/journal.pone.0195838","volume":"13","author":"S Lee","year":"2018","unstructured":"Lee S, Zimmerman ME, Narkhede A, Nasrabady SE, Tosto G, Meier IB, et al. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer\u2019s disease. PLoS One. 2018;13:e0195838.","journal-title":"PLoS One"},{"key":"3927_CR33","doi-asserted-by":"publisher","first-page":"fcaa132","DOI":"10.1093\/braincomms\/fcaa132","volume":"2","author":"KK Laing","year":"2020","unstructured":"Laing KK, Simoes S, Baena-Caldas GP, Lao PJ, Kothiya M, Igwe KC, et al. Cerebrovascular disease promotes tau pathology in Alzheimer\u2019s disease. Brain Commun. 2020;2:fcaa132.","journal-title":"Brain Commun"},{"key":"3927_CR34","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1161\/01.STR.28.3.652","volume":"28","author":"L Pantoni","year":"1997","unstructured":"Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke. 1997;28:652\u20139.","journal-title":"Stroke"},{"key":"3927_CR35","doi-asserted-by":"publisher","DOI":"10.34133\/cbsystems.0087","volume":"5","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang C, Qi J, Peng Y. Leave it to large language models! correction and planning with memory integration. Cyborg Bionic Syst. 2024;5:0087.","journal-title":"Cyborg Bionic Syst"},{"key":"3927_CR36","doi-asserted-by":"publisher","first-page":"0441","DOI":"10.34133\/cbsystems.0441","volume":"6","author":"A Mencattini","year":"2025","unstructured":"Mencattini A, Curci G, Riccardi A, Casti P, D\u2019Orazio M, Filippi J, et al. MEA-Based graph deviation network for early autism syndrome signatures in human forebrain organoids. Cyborg Bionic Syst. 2025;6:0441.","journal-title":"Cyborg Bionic Syst"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03927-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03927-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03927-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:53:03Z","timestamp":1773301983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03927-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3927"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-03927-5","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflict of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of Hainan General Hospital in accordance with the Declaration of Helsinki. All participants and\/or their respective Legally Authorized Representative (when applicable) provided their written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"140"}}